NuVasive (NUVA) received regulatory Shonin approval for ReLine™ posterior fixation technology in Japan. Launch will commence later in 2016 and continue into 2017.
This approval supports the pending Japan launch of the Integrated Global Alignment or iGA platform for spinal alignment.
NUVA is planning for >30% growth in its Japanese market for 2016. The company cites Japan as the world’s second largest spine market and NUVA’s largest market ex-U.S. NUVA first entered the Japanese market in 2013, with its Precept® posterior fixation system.
NuVasive (NUVA) received regulatory Shonin approval for ReLine™ posterior fixation technology in Japan. Launch will commence later in 2016 and continue into 2017.
This approval supports the pending Japan launch of the Integrated Global Alignment or iGA platform for spinal alignment.
NuVasive (NUVA) received regulatory Shonin approval for ReLine™ posterior fixation technology in Japan. Launch will commence later in 2016 and continue into 2017.
This approval supports the pending Japan launch of the Integrated Global Alignment or iGA platform for spinal alignment.
NUVA is planning for >30% growth in its Japanese market for 2016. The company cites Japan as the world’s second largest spine market and NUVA’s largest market ex-U.S. NUVA first entered the Japanese market in 2013, with its Precept® posterior fixation system.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE
ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
Copy to clipboard 
